课题基金 / 基金详情

Identification of inhibitor of osteoclastogenesis

Identification of inhibitor of osteoclastogenesis
破骨细胞生成抑制剂的鉴定
批准号:
10671734
负责人:
MORITA Ikuo
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

MORITA Ikuo的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this research was to purify and identify inhibitors of osteoclast formation released from mouse stromal cells (pre-osteoblasts, TMS-12). To quantify the activity of inhibition of osteoclast formation, we developed the assay system for osteoclast formation, and to purify the inhibitors we determined the cultured condition of TMS-14 without serum. Using this system, we carried out the purification of inhibitors from the 120 liter of the conditioned medium of TMS-14 with ion-exchangers, molecular cutting, dialysis and so on. Finally after applying Superdex 200HR10/30 it was determined that the molecular of the inhibitors was 200K and 22K. Now, we carry out the cloning of this substances. Next, we characterized the inhibitors. As a result, the inhibitors were characterized as follows ; 1) It was determined the inhibitors was not IL-4, IL-10, TNFα, known-inhibitors of osteoclast formation by the experiments of antibody neutrization, 2) The substances inhibited osteoclast differentiation, but not proliferation of osteoclast progenitor cells, 3) The substances also changed the morphology of mature osteoclasts and inhibited the pit formation.These data indicated that the characterization of the inhibitors of osteoclast formation was quietly different from other inhibitors such as osteoprotegrin/osteoclastogenesis inhibitory factor.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Sakaguchi K, Morita I, Murota S: "Relationship between the ability to support differentiation of osteoclast-like cells and adipogenesis in murine stromal cells derived from bone marrow."Prostaglandins, Leukotrienes and Essential Fatty Acids. (in press).
Sakaguchi K、Morita I、Murota S:“支持破骨细胞样细胞分化的能力与源自骨髓的小鼠基质细胞中的脂肪形成之间的关系。”前列腺素、白三烯和必需脂肪酸。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Gao Y.Morita I et al.: "Expression of IL-6 receptor and GP130 in mouse bonemarrow cells during osteoclast differentiation"Bone. 22. 487-493 (1998)
高 Y.Morita I 等:“破骨细胞分化过程中小鼠骨髓细胞中 IL-6 受体和 GP130 的表达”骨。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sato T. Morita I. Murota S.: "Involvement of cholesterol in osteoclast-like cell formation via cellular fusion."Bone. 23(2). 135-140 (1998)
Sato T. Morita I. Murota S.:“胆固醇通过细胞融合参与破骨细胞样细胞的形成。”骨。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sakaguchi K, Morita I, Murota S: "Relationship between the ability to support differentaition of osteoclast-like cells and adipogenesis in murine stromal cells derived from bone marrow."Postaglandins,Leukotrienes and Essential Fatty Acids. (in press). (20
Sakaguchi K、Morita I、Murota S:“支持破骨细胞样细胞分化的能力与源自骨髓的小鼠基质细胞中的脂肪生成之间的关系。”前列腺素、白三烯和必需脂肪酸。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    Development of novel therapies for myopia by printing technology
    • 批准号:
      25670728
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MORITA Ikuo
    • 依托单位:
    A novel periodontal tissue regeneration method using a printing technology
    • 批准号:
      24390442
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2012
    • 负责人:
      MORITA Ikuo
    • 依托单位:
    Development of tissue engineering for three-dimensional tissue regeneration
    • 批准号:
      22659354
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.06万
    • 财政年份:
      2010
    • 负责人:
      MORITA Ikuo
    • 依托单位:
    Mechanism for maintenance of homeostasis of several functions by connexin 43
    • 批准号:
      20390470
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2008
    • 负责人:
      MORITA Ikuo
    • 依托单位: